CSF proteomic analysis in patients with normal pressure hydrocephalus selected for the shunt: CSF biomarkers of response to surgical treatment

Neurol Sci. 2010 Jun;31(3):283-91. doi: 10.1007/s10072-009-0181-0. Epub 2009 Nov 21.

Abstract

The aim of our pilot study was to investigate, by a proteomic approach, the expressed differences in cerebrospinal fluid (CSF) protein patterns in order to aid in the diagnosis and treatment of normal pressure hydrocephalus (NPH). Seventeen patients with NPH, selected by Intracranial-Pressure monitoring (ICPmo), underwent implantation of a shunt and after 6 months were clinically re-evaluated. Thirteen patients improved, whereas four did not. During ICPmo CSF was collected and its proteoma was analyzed by 2D gel electrophoresis and mass spectrometry. The over-expression of alpha2HS glycoprotein, alpha1 antichimotrypsin and alpha1beta glycoprotein and the under-expression of glial fibrillary acidic protein, apolipoproteins (AIV, J and E), complement C3c, anti-thrombin, alpha2 antiplasmin and albumin seem to be associated with a positive response to surgery. Most of these proteins have been reported to be altered in Alzheimer disease, supporting the hypothesis of a possible link between these two nosological entities.

MeSH terms

  • Aged
  • Biomarkers / cerebrospinal fluid
  • Cerebrospinal Fluid Shunts*
  • Electrophoresis, Gel, Two-Dimensional
  • Female
  • Follow-Up Studies
  • Humans
  • Hydrocephalus, Normal Pressure / cerebrospinal fluid*
  • Hydrocephalus, Normal Pressure / diagnosis
  • Hydrocephalus, Normal Pressure / surgery*
  • Intracranial Pressure
  • Male
  • Patient Selection
  • Peptide Mapping
  • Pilot Projects
  • Proteome
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Proteome